Revision history of "Role of podocalicin in the development of non-Hodgkin B-cell lymphomas" (Q3166008)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:4009:40, 11 October 2024DG Regio talk contribs 79,818 bytes 0 Changed label, description and/or aliases in pt
  • curprev 09:4009:40, 11 October 2024DG Regio talk contribs 79,818 bytes +55 Set a claim value: summary (P836): Os linfomas não-Hodgkin de células B (LNH) constituem um grupo muito heterogéneo de doenças linfoproliferativas malignas, tanto biológica como clinicamente, consistindo em mais de 40 neoplasias que vão desde doenças indolentes a doenças altamente agressivas. Embora a sobrevida após o tratamento quimioterapêutico tenha aumentado nos últimos anos, alguns pacientes com LNH de células B apresentam recidiva devido à resistência aos fármacos, com prognóst...

7 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 09:4809:48, 4 August 2022DG Regio talk contribs 78,490 bytes +54,075 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 17:2017:20, 12 October 2021DG Regio talk contribs 13,006 bytes +2,534 Created claim: summary (P836): B-cell non-Hodgkin lymphomas (NHL) constitute a very heterogeneous group of malignant lymphoproliferative diseases, both biologically and clinically, consisting of more than 40 neoplasms ranging from indolent to highly aggressive diseases. Although survival after chemotherapeutic treatment has increased in recent years, some patients with B-cell NHL are relapsed due to drug resistance, presenting unfavorable prognosis, so the identification of n...
  • curprev 17:2017:20, 12 October 2021DG Regio talk contribs 10,472 bytes −2,534 Removed claim: summary (P836): B-cell non-Hodgkin lymphomas (NHL) constitute a very heterogeneous group of malignant lymphoproliferative diseases, both biologically and clinically, consisting of more than 40 neoplasms ranging from indolent to highly aggressive diseases. Although survival after chemotherapeutic treatment has increased in recent years, some patients with B-cell NHL are relapsed due to drug resistance, presenting unfavorable prognosis, so the identification of...
  • curprev 16:3016:30, 12 October 2021DG Regio talk contribs 13,006 bytes +129 Changed label, description and/or aliases in en: translated_label
  • curprev 16:3016:30, 12 October 2021DG Regio talk contribs 12,877 bytes +2,534 Created claim: summary (P836): B-cell non-Hodgkin lymphomas (NHL) constitute a very heterogeneous group of malignant lymphoproliferative diseases, both biologically and clinically, consisting of more than 40 neoplasms ranging from indolent to highly aggressive diseases. Although survival after chemotherapeutic treatment has increased in recent years, some patients with B-cell NHL are relapsed due to drug resistance, presenting unfavorable prognosis, so the identification of n...

10 October 2021

9 October 2021

8 October 2021